How Insilico Medicine Uses AI To Accelerate Drug Development

Alex Zhavoronkov is a well-known figure in the community of longevity researchers for his unwavering dedication. He doesn't take any breaks and works seven days a week. The effort is bearing fruit: The first phase 1 clinical trials for an entirely AI-developed medicine were reported in February by the business he created, Insilico Medicine. The company is now well-funded after a number of investment rounds during the remainder of the year, and its software is widely used in the pharmaceutical industry. The most recent episode of the London Futurist Podcast features Alex discussing the company's development. Drug development is done in three stages. Although drug development is a lengthy and complex process, it may be divided into three stages. You start by formulating a theory regarding the origin of the ailment.